Archives
- 2018-07
- 2018-10
- 2018-11
- 2019-04
- 2019-05
- 2019-06
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-07
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
-
In practical terms as described in Becker and Ichino or
2018-11-15
In practical terms, as described in Becker and Ichino (2002) or Khandker et al. (2010), to sustain these two hypotheses, one chooses a sub-sample following the protocol of matching the treatment and control groups (leaving the sub-sample components sufficiently similar in terms of covariates). In th
-
Neutrophils are one of the first responding immune cells
2018-11-15
Neutrophils are one of the first responding immune cells to an infection. The migration of neutrophils into the site of infection–inflammation is mediated by PAMPs from microbes or DAMPs derived from disrupted host cells. At the site of infection, neutrophils rapidly combat pathogens by unleashing R
-
The gain of q is
2018-11-14
The gain of 20q11.21 is not specific to pluripotent toll like receptors and is a common feature of many screened cancer cells and cancer types in which knockdown of BCL2L1 is detrimental to cancer cell proliferation (Beroukhim et al., 2010). It has also been suggested that 20q amplification is stro
-
We differentiated the iPSCs into OL lineage cells and
2018-11-14
We differentiated the iPSCs into OL lineage jak inhibitors and examined the pathogenic changes in the PMD iPSC-derived OLs. We confirmed the accumulation and mislocalization of mutant PLP1 proteins to the ER, a high level of stress susceptibility, and increased apoptosis in PMD iPSC-derived OLs. In
-
Since the spoken language of the
2018-11-14
Since the spoken language of the dolphin consists of spectral extrema that act as phonemes, we can hypothesize that it serine protease inhibitors has both phonological and grammatical structures, so dolphins can create an infinite number of words from a finite number of spectral extrema, which can
-
In agreement with the results of the
2018-11-14
In agreement with the results of the previous studies conducted in our laboratory, it was found that the regulation of the STIM2→nSOCE signaling pathway was impaired in 5×FAD mice. It was established that downregulated STIM2 expression was observed as early as at the age of 4 months. At this age, do
-
br Methods br Results VIS is an engineered human
2018-11-14
Methods Results VIS410 is an engineered human IgG1 antibody that targets a unique, conserved conformational epitope on the stem of Influenza A virus HA protein (Tharakaraman et al., 2015). Previous studies have identified that VIS410 has broad reactivity against both group 1 and group 2 influe
-
Understanding how barrier tissues function is
2018-11-14
Understanding how barrier tissues function is essential for the design of effective pharmaceutical compounds. Once these devices are transitioned from research to clinical use, and we have more accurate predictive models early on in the development process, we will likely see an end to the recent st
-
We have shown that long
2018-11-14
We have shown that long-term WL/CR modulates adipocyte differentiation of ASCs in human sWAT by inducing both positive and negative regulators of the IGF-1 system at early stages of adipogenesis. Importantly, we identified DIRAS3 as novel negative regulator of adipogenesis, which slows down this pro
-
harpagoside In principle the screening for any type of drug
2018-11-14
In principle, the screening for any type of drug resistance by searching for mutations in inhA, katG, and rpoB would allow to limit phenotypic DST to isolates with a harpagoside identified in inhA, katG, and rpoB. Limiting phenotypic DST to isolates with a mutation identified in inhA, katG, or rpoB
-
We have previously reported the CM chip that enables
2018-11-14
We have previously reported the CM chip that enables precise estimation of rare cell counts in blood including spiked-in cultured cancer amyloid (Yatsushiro et al., 2010; Yamamura et al., 2012). Although the CM chip produced excellent results in a preclinical study, we considered that precise enume
-
Progress toward the treatment of three major parasitic disea
2018-11-14
Progress toward the treatment of three major parasitic diseases (sleeping sickness, Chagas disease, and leishmaniasis) was recently demonstrated in an article published online last month in the journal (August 8, 2016). Collectively, these three diseases affect 20 million people per year, resulting
-
Although some earlier studies reported significant differenc
2018-11-14
Although some earlier studies reported significant differences in RFS and PFS rates between risk groups (Xu et al., 2013; Altieri et al., 2012; Van Rhijn et al., 2010), other studies including ours (Fig. 1), found that prediction of both recurrence and progression were poorly discriminated by the EO
-
br Methods CHC patients receiving anti
2018-11-14
Methods CHC patients receiving anti-viral therapy were consecutively recruited as a prospective follow-up cohort at one tertiary hospital and two core regional hospitals from 2002 to 2012. All the participants received peginterferon alpha-2a or peginterferon alpha-2b plus ribavirin. Patients were
-
The outcome measures of efficacy of antibody replacement the
2018-11-14
The outcome measures of efficacy of antibody replacement therapy are summarized in Table 3 and Fig. 1. Anamnestically patients had a median number of 5.50 infections per year (interquartile range 4.00–8.00; available in 50 patients). In the year prior to ART the median number of antibiotic courses w
15207 records 989/1014 page Previous Next First page 上5页 986987988989990 下5页 Last page